Cracking Down on Harmful Drug Combinations

In the intricate landscape of pharmaceuticals, patient safety and the efficacy of medicines are nonnegotiable priorities.

- 

Yet, irrational or harmful fixed-dose combinations (FDCs) have long undermined these goals, posing significant risks through side effects, misuse, and drug dependency. Maharashtra’s Food and Drug Administration (FDA) is taking decisive action to eliminate such hazardous formulations from the market, reinforcing its commitment to public health.

Understanding the Problem

FDCs combine two or more active pharmaceutical ingredients into a single preparation. While some offer therapeutic benefits and improve treatment adherence, others lack scientific justification or present heightened safety risks. Dangerous examples include narcotic and psychotropic substances blended unlawfully—such as the potent painkiller Tapentadol mixed with muscle relaxant Carisoprodol—raising serious concerns about abuse and adverse effects.